Subtle Medical
PrivateLast Round
Series C
Jun 2, 2026
Total Funding Raised
$61.03M
Company Overview
Subtle Medical, Inc. is a healthcare technology company that provides artificial intelligence (AI)-powered software solutions to improve medical imaging. Founded in 2017 out of Stanford University research, the company's products integrate with existing MRI and PET scanners to enhance image quality, accelerate scan times, and reduce the need for contrast agents or radiation doses. Its flagship products, SubtleMR™ and SubtlePET™, are FDA-cleared and CE-marked, and are used by hundreds of hospitals and imaging centers globally. The company has raised over $50 million in total financing from investors including Bessemer Venture Partners, Samsung Ventures, and Fusion Fund to support its global sales initiatives and the development of new products.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Subtle Medical Comps
Public and private peers based on sector, stage, and business model.
Subtle Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 2, 2026 | ||||
| Series B Extension | Jul 24, 2024 | ||||
| Grant | Sep 13, 2023 | ||||
| Series B | Nov 17, 2022 | ||||
| Series A | Nov 19, 2020 | ||||
Grant | Aug 13, 2020 |
Key People
Founding team and executive leadership
Subtle Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BRV Capital Management | Series B Extension, Series C |
| Breyer Capital | Seed |
| Morgan Stanley Expansion Capital | Series C |
| Shinhan Venture Investment | Series C |
| Fusion Fund | Series B, Seed, Series A, Series B Extension, Series C |
| Nina Capital | Series A |
| StartX | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$33M round led by Morgan Stanley Expansion Capital.
- Apr 1, 2026
Solutions deployed on over 1,000 scanners globally.
Subtle Medical Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Subtle Medical's valuation, stock price, and market status.
